Of particular interest, this study demonstrated that inhibition of USP7 could sensitise HPV- HNSCC cells to both radiation treatment and PARP inhibition, suggesting that combination therapies may be beneficial in these cancers [103]. This evidence concerns the gene USP7 and head and neck squamous cell carcinoma.